Risk assessment of endocrine disrupting substances can be used if requisite and sufficient data on environmental exposure, the effects on sensitive species and life stages, and where relevant, delayed ...
Newly developed chemical substances or cosmetics can be distributed only after passing the risk assessment in human and environment. The developed product distribution is prohibited if it cannot pass ...
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months After a median follow-up of 6.6 ...
Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. However, for many chemicals, ...
Thyroid and breast cancers are common, affecting women more than men. In their recent review article, Halada et al. detail inter-relationships between these two cancers -- common signaling pathways, ...
Association of genetic predisposition to low-grade systemic inflammation with cancer-related fatigue in women receiving chemotherapy for non-metastatic breast cancer in URCC07012 and URCC10055.
The endocrine system is the name for the glands that produce hormones in a person’s body. These glands include the thyroid gland, pituitary gland, and adrenal gland. The endocrine system produces ...
Growth hormone insensitivity (GHI) describes a range of disorders in which there is resistance to the actions of growth hormone. This review focuses on three areas where advances contribute to ...
With this background, we need to consider the strengths and limitations of the report by Phillips et al (2016) in this issue of the British Journal of Cancer, describing an evaluation of cognitive ...
The endocrine system uses chemical messengers called hormones to regulate a range of bodily functions through the release of hormones. The endocrine system is a network of glands and organs located ...
Pituitary neuroendocrine tumors (PitNETs) are commonly associated with visual disturbances and endocrine abnormalities; however, many patients also ...
Results of the SETAC Pellston Workshop "Environmental Hazard and Risk Assessment Approaches for Endocrine-Active Substances" (EHRA) were recently published in Integrated Environmental Assessment and ...